Evaluation of resistance development and viability recovery by a non-enveloped virus after repeated cycles of aPDT

Antiviral Research

Volumn 91, Issue 3, 2011, Pages 278-282

  Costa, Liliana ^a   Tomé, João P C ^a   Neves, Maria G P M S ^a   Tomé, Augusto C ^a   Cavaleiro, José A S ^a   Faustino, Maria A F ^a   Cunha, Ângela ^a   Gomes, Newton C M ^a   Almeida, Adelaide ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Antimicrobial photodynamic therapy (aPDT); Bacteriophages; Porphyrin; Resistance; Viability recovery

Indexed keywords

5,10,15 TRIS(1 METHYLPYRIDINIUM 4 YL) 20 (PENTAFLUOROPHENYL)PORPHYRIN TRI IODIDE; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIOPHAGE T4; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; IRRADIATION; LYSIS; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SUSPENSION; VIRUS INFECTION; VIRUS SURVIVAL; VIRUS VIABILITY; WHITE LIGHT;

BACTERIOPHAGES; DRUG RESISTANCE, VIRAL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; HUMANS; LIGHT; MICROBIAL VIABILITY; MODELS, BIOLOGICAL; PHOTOCHEMICAL PROCESSES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SERIAL PASSAGE; VIRUS INACTIVATION;

EID: 79960467543     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.06.007     Document Type: Article

References (46)

1. Adams M.H. Bacteriophages 1959, Interscience, New York.
2. Calin M.A., Parasca S.V. Light sources for photodynamic inactivation of bacteria. Lasers Med. Sci. 2009, 24:453-460.
3. Carvalho C.M.B., Alves E., Costa L., Tomé J.P.C., Faustino M.A.F., Neves G.P.M.S., Tomé A., Cavaleiro J.A.S., Almeida A., Cunha A., Lin Z., Rocha J. Functional cationic nanomagnet-porphyrin hybrids for the photoinactivation of microorganisms. ACS Nano. 2010, 4:7133-7140.
4. Cheng Y., Tsou L.K., Cai J., Aya T., Dutschman G.E., Gullen E.A., Grill S.P., Chen A.P.-C., Lindenbach B.D., Hamilton A.D., Cheng Y.-C. A novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against hepatitis C virus genotype 1b replicons in vitro. Antimicrob. Agents Chemother. 2010, 54:197-206.
5. Cookson B. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 1998, 41:11-18.
6. Costa L., Alves E., Carvalho C.M.B., Tomé J.P.C., Faustino M.A.F., Neves M.G.P.M.S., Tomé A.C., Cavaleiro J.A.S., Cunha A., Almeida A. Sewage bacteriophage photoinactivation by cationic porphyrins: a study of charge effect. Photochem. Photobiol. Sci. 2008, 7:415-422.
7. DeRosa M. Photosensitized singlet oxygen and its applications. Coord. Chem. Rev. 2002, 233-234. 351-371.
8. Duwe S., Brunn M., Altmann D., Hamouda O., Schmidt B., Walter H., Pauli G., Kücherer C. Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study. J. Acq. Immun. Def. Synd. 2001, 26:266-273.
9. Egyeki M., Turóczy G., Majer Z., Tóth K., Fekete A., Maillard P., Csík G. Photosensitized inactivation of T7 phage as surrogate of non-enveloped DNA viruses: efficiency and mechanism of action. BBA-Gen. Subjects 2003, 1624:115-124.
10. Embleton M.L., Nair S.P., Cookson B.D., Wilson M. Antibody directed photodynamic therapy of methicillin-resistant Staphylococcus aureus. Microb. Drug. Resist. 2004, 10:92-97.
11. Ergaieg K., Chevanne M., Cillard J., Seux R. Involvement of both Type I and Type II mechanisms in Gram-positive and Gram-negative bacteria photosensitization by a meso-substituted cationic porphyrin. Sol. Energy. 2008, 82:1107-1117.
12. Fridkin S.K. Vancomycin-intermediate and-resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin. Infect. Dis. 2001, 32:108-115.
13. Grinholc M., Szramka B., Kurlenda J., Graczyk R., Bielawski K.P. Bactericidal effect of photodynamic inactivation against methicillin-resistant and methicillin-susceptible Staphylococcus aureus is strain-dependent. J. Photochem. Photobiol. B 2008, 90:57-63.
14. Hadjur C., Lange N., Rebstein J., Monnier P., van den Bergh H., Wagnières G. Spectroscopic studies of photobleaching and photoproduct formation of meta(tetrahydroxyphenyl)chlorin (m-THPC) used in photodynamic therapy. The production of singlet oxygen by m-THPC. J. Photochem. Photobiol. B 1998, 45:170-178.
15. Hamblin M.R., Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease?. Photochem. Photobiol. Sci. 2004, 3:436-450.
16. Jori G., Fabris C., Soncin M., Ferro S., Coppellotti O., Dei D., Fantetti L., Chiti G., Roncucci G. Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Laser Surg. Med. 2006, 38:468-481.
17. Kim S.Y., Kwon O.J., Park J.W. Inactivation of catalase and superoxide dismutase by singlet oxygen derived from photoactivated dye. Biochimie. 2001, 83:437-444.
18. Kimberlin D.W., Whitley R.J. Antiviral resistance: mechanisms, clinical significance, and future implications. J. Antimicrob. Chemother. 1996, 37:403-421.
19. Kömerik N., Wilson M., Poole S. The effect of photodynamic action on two virulence factors of Gram-negative bacteria. Photochem. Photobiol. 2000, 72:676-680.
20. Konopka K., Goslinski T. Photodynamic therapy in dentistry. Crit. Rev. Oral Biol. Med. 2007, 694-707.
21. Lauro F.M., Pretto P., Covolo L., Jori G., Bertoloni G. Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates. Photochem. Photobiol. Sci. 2002, 1:468-470.
22. Li H., Fedorova O.S., Grachev A.N., Trumble W.R., Bohach G.A., Czuchajowski L. A series of meso-tris (N-methyl-pyridiniumyl)-(4-alkylamidophenyl) porphyrins: synthesis, interaction with DNA and antibacterial activity. Biochim. Biophys. Acta. 1997, 1354:252-260.
23. Maclean M., Macgregor S.J., Anderson J.G., Woolsey G.A. The role of oxygen in the visible-light inactivation of Staphylococcus aureus. J. Photochem. Photobiol. B 2008, 92:180-184.
24. Madigan M.T., Martinko J.M. Brock Biology of Microorganisms 2006, Pearson Prentice Hall, Upper Saddle River, NJ. 11th ed.
25. Maisch T., Bosl C., Szeimies R., Lehn N., Abels C. Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob. Agents Chemother. 2005, 49:1542-1552.
26. Maisch T., Szeimies R.-M., Jori G., Abels C. Antibacterial photodynamic therapy in dermatology. Photochem. Photobiol. Sci. 2004, 3:907-917.
27. Maisch T. Anti-microbial photodynamic therapy: useful in the future?. Laser Med. Sci. 2007, 22:83-91.
28. Mettath S., Munson B.R., Pandey R.K. DNA interaction and photocleavage properties of porphyrins containing cationic substituents at the peripheral position. Bioconjugate Chem. 1999, 10:94-102.
29. Müller-Breitkreutz K., Mohr H., Briviba K., Sies H. Inactivation of viruses by chemically and photochemically generated singlet molecular oxygen. J. Photochem. Photobiol. B 1995, 30:63-70.
30. Nishijima S., Namura S., Mitsuya K., Asada Y. The incident of isolation of methicillin-resistant Staphylococcus aureus (MRSA) strains from skin infections during the past three years (1989-1991). J. Dermatol. 1993, 20:193-197.
31. Nitzan Y., Shainberg B., Malik Z. The mechanism of photodynamic inactivation of Staphylococcus aureus by deuteroporphyrin. Curr. Microbiol. 1989, 19:265-269.
32. North J., Coombs R., Levy J. Photodynamic inactivation of free and cell associated HIV-1 using the PS, benzo porphyrin derivative. J. Acq. Immun. Def. Synd. 1994, 7:891-898.
33. Oliveira A., Almeida A., Carvalho C.M.B., Tomé J.P., Faustino M.A., Neves M.G., Tomé A.C., Cavaleiro J.A., Cunha A. Porphyrin derivatives as photosensitizers for the inactivation of Bacillus cereus endospores. J. Appl. Microbiol. 2009, 106:1986-1995.
34. Pedigo, L.A., Gibbs, A.J., Scott, R.J., Street, C.N., 2009. Absence of bacterial resistance following repeat exposure to photodynamic therapy. Proc SPIE 7380-73803H. doi:10.1117/12.822834.
35. Pillay D. Emergence and control of resistance to antiviral drugs in resistance in herpes viruses, hepatitis B virus, and HIV. CDPH 1998, 1:5-13.
36. Sievert D., Boulton M., Stoltman G., Johnson D., Stobierski M.G., Downes F.P., Somsel P.A., Rudrik J.T. Staphylococcus aureus resistant to vancomycin - United States. Morb. Mortal. Wkly. Rep. 2002, 51:565-567.
37. Tamalet C., Pasquier C., Yahi N., Colson P., Poizot-Martin I., Lepeu G., Gallais H., Massip P., Puel J., Izopet J. Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection. J. Med. Virol. 2000, 61:181-186.
38. Tavares A., Carvalho C.M.B., Faustino M.A., Neves M.G.P.M.S., Tomé J.P.C., Tomé A.C., Cavaleiro J.A.S., Cunha A., Gomes N.C.M., Alves E., Almeida A. Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment. Mar. Drugs. 2010, 8:91-105.
39. Taylor P.W., Stapleton P.D., Luzio J.P. New ways to treat bacterial infections. Drug Discov. Today 2002, 7:1086-1091.
40. Trannoy L.L., Terpstra F.G., Korte de K., Lagerberg J.W., Verhoeven A.J., Brand A., van Engelenburg F.A. Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation. Vox Sang. 2006, 2:111-118.
41. Vzorov A.N., Dixon D.W., Trommel J.S., Marzilli L.G., Compans R.W. Inactivation of human immunodeficiency virus type 1 by porphyrins. Antimicrob. Agents Chemother. 2002, 46:3917-3925.
42. Wainwright M. Photoantimicrobials - so what's stopping us?. Photodiagn. Photodyn. 2009, 6:167-169.
43. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J. Antimicrob. Chemother. 1998, 42:13-28.
44. Wainwright M., Crossley K. Photosensitising agents-circumventing resistance and breaking down biofilms: a review. Int. Biodeter. Biodegr. 2004, 53:119-126.
45. Winckler K.D. Special section: focus on anti-microbial photodynamic therapy (PDT). J. Photochem. Photobiol. B 2007, 86:43-44.
46. Zupán K., Herényi L., Tóth K., Majer Z., Csík G. Binding of cationic porphyrin to isolated and encapsulated viral DNA analyzed by comprehensive spectroscopic methods. Biochemistry 2004, 43:9151-9159.